Q1a) Is any of the product(s) purchased/used in your hospital contain Chitin/Chitosan (e.g. surgical sutures, materials in wound healing/tissue engineering/dentistry/drug delivery)?
If the answer to Q1a is Yes then skip to Q2a.
If the answer to Q1a is No then:
Q1b) Do you plan on utilizing products containing Chitin/Chitosan in the next two years?
If the answer to Q1b is No, you may skip the rest of the questionnaire.
If the answer to Q1b is Yes, answer Q2a and then you may skip the rest of the questionnaire.
Q2a) What product(s) do you have in the hospital (or intend to purchase) that contains Chitin/Chitosan?
Q2b) For each product listed in response to Question Q2a, could you please provide the following details:
I. The product’s brand name.
II. The purpose of the product and in which department it is used.
III. The approximate volume of the product used/purchased over the last financial year (1st April 2022 – 31st March 2023).
Q3) Has the hospital received any complaints or filed any cases of side effects from using the Chitin/Chitosan product(s) mentioned above? If so, please provide detail of the following:
a) Number of cases in years 2020, 2021, 2022 and 2023
b) description of the most three common side effects
c) Which product(s) caused the most commonly seen side effects
Q4) Is there any limitation(s), certification(s), or regulatory requirement(s) that are bounded when utilizing Chitin/Chitosan in the hospital (i.e. ISO standards or Ethics, etc)? If so, please specify.
Q5) Is the hospital currently or will be promoting any new products containing chitin or chitosan?
